117
Views
4
CrossRef citations to date
0
Altmetric
Short Report

Infiltrating Treg and Th17 Cells of the Prostate Hypertrophy Gland Associated with Propionibacterium Acnes Infection

, , , ORCID Icon, &
Pages 593-597 | Published online: 30 Nov 2020

References

  • Cai T, Santi R, Tamanini I, et al. Current knowledge of the potential links between inflammation and prostate cancer. Int J Mol Sci. 2019;20:3833.
  • Korniluk A, Koper O, Kemona H, Dymicka-Piekarska V. From inflammation to cancer. Ir J Med Sci. 2017;186(1):57–62. doi:10.1007/s11845-016-1464-027156054
  • McLaughlin J, Watterson S, Layton AM, Bjourson AJ, Barnard E, McDowell A. Propionibacterium acnes and Acne Vulgaris: new insights from the integration of population genetic, multi-omic, biochemical and host-microbe studies. Microorganisms. 2019;7(5):128. doi:10.3390/microorganisms7050128
  • Achermann Y, Goldstein EJ, Coenye T, Shirtliff ME. Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev. 2014;27:419–440.24982315
  • Kakegawa T, Bae Y, Ito T, et al. Frequency of Propionibacterium acnes infection in prostate glands with negative biopsy results is an independent risk factor for prostate cancer in patients with increased serum PSA titers. PLoS One. 2017;12(1):e0169984. doi:10.1371/journal.pone.016998428081259
  • Dadashi M, Eslami G, Taghavi A, et al. Is Propionibacterium acnes a causative agent in benign prostate hyperplasia and prostate cancer? Arch Clin Infect Dis. 2018;13(3):e58947. doi:10.5812/archcid.58947
  • Kistowska M, Meier B, Proust T, et al. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients. J Invest Dermatol. 2015;135(1):110–118. doi:10.1038/jid.2014.29025010142
  • Liu J, Duan Y, Cheng X, et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun. 2011;407(2):348–354. doi:10.1016/j.bbrc.2011.03.02121396350
  • Saleh R, Elkord E. FoxP3+ T regulatory cells in cancer: prognostic biomarkers and therapeutic targets. Cancer Lett. 2020;490:174–185. doi:10.1016/j.canlet.2020.07.02232721551
  • Fabre J, Giustiniani J, Garbar C, et al. Targeting the tumor microenvironment: the protumor effects of IL-17 related to cancer type. Int J Mol Sci. 2016;17(9):1433. doi:10.3390/ijms17091433
  • Shou J, Zhang Z, Lai Y, Chen Z, Huang J. Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs: a systematic review and meta-analysis. BMC Cancer. 2016;16(1):687. doi:10.1186/s12885-016-2732-027566250
  • Tang Y, Xu X, Guo S, et al. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma. PLoS One. 2014;9(3):e91551. doi:10.1371/journal.pone.009155124637664